Today: 30 June 2026
Intuit stock price dips again as Morgan Stanley maps a “Triple Double” path for INTU
21 January 2026
2 mins read

Intuit stock price dips again as Morgan Stanley maps a “Triple Double” path for INTU

New York, Jan 21, 2026, 11:39 ET — Regular session

  • Intuit shares slipped roughly 0.6%, hitting $525.93 in late morning trading
  • Morgan Stanley outlined a bull case focused on mid-market accounting and boosted tax-related growth
  • Investors are focused on Intuit’s annual stockholder meeting set for Jan. 22 and the quarter-end on Jan. 31

Shares of Intuit Inc dipped roughly 0.6% on Wednesday, slipping to $525.93 despite Morgan Stanley’s bullish long-term outlook, which sees the stock potentially doubling in value.

This move is crucial as Intuit enters the core of U.S. tax season, a key window for its TurboTax arm and investor sentiment. Shares have dropped from their peaks, so Wall Street is eager for signs that demand remains strong and fresh growth strategies are gaining traction.

Morgan Stanley’s Keith Weiss highlighted Intuit as being in the “early days of two compelling product cycles”: mid-market accounting and assisted tax. These markets are valued at $89 billion and $37 billion, respectively. Weiss sees a “credible path to 20% growth,” citing 40% growth in the mid-market segment for fiscal 2025 and 47% growth in TurboTax Live. He laid out a “Triple Double” bull case where revenue, earnings per share, and the stock price each nearly double by fiscal 2030. The note values Intuit shares at 22 times next-twelve-month earnings, the cheapest multiple since 2014. https://www.investing.com/news/stock-marke…

Intuit dropped 3% Tuesday, closing at $528.95 amid a broad market selloff. The stock now trades roughly 35% below its 52-week peak of $813.70 hit on July 30, per MarketWatch data. Other software stocks also took hits—Adobe, Paychex, and Oracle all ended the day lower.

On Wednesday, the market edged down despite the wider U.S. indexes showing some recovery following Tuesday’s drop. The S&P 500 was about 1% higher by mid-day, the Associated Press reported.

The stock is caught between two conflicting narratives: a tax-and-small-business franchise that generates steady cash flow in strong years, and a software multiple that can shrink quickly when investors shift away from high-growth stocks. Intuit’s portfolio features TurboTax, QuickBooks, Credit Karma, and Mailchimp.

In November, Intuit forecasted second-quarter revenue growth between 14% and 15%, with non-GAAP EPS ranging from $3.63 to $3.68. The company’s fiscal second quarter wraps up on Jan. 31. CFO Sandeep Aujla expressed confidence in hitting double-digit revenue growth and margin expansion for fiscal 2026.

The annual stockholder meeting is scheduled for Thursday at 8:00 a.m. Pacific time. Intuit said CEO Sasan Goodarzi will review fiscal 2025 results and outline the company’s strategy.

For traders, the key question is straightforward: will the stock find a bottom after several down days, or will it continue slipping even as the broader market climbs?

There’s a risk tax-season volumes fall short, or that growth in assisted tax offerings like TurboTax Live slows after a strong year earlier. Expanding into bigger business clients might also prove slower and pricier than bulls expect, leaving the stock vulnerable if guidance gets more conservative.

Thursday’s shareholder meeting is next on the agenda, then the focus shifts to the Jan. 31 quarter-end. That’s when investors will begin pushing for early indicators on tax-season demand, Credit Karma lending patterns, and how well QuickBooks is holding onto small-business clients.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals
Previous Story

UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals

Accenture stock price rises as Palantir-backed “sovereign AI” data-center deal grabs focus
Next Story

Accenture stock price rises as Palantir-backed “sovereign AI” data-center deal grabs focus

Go toTop